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Abstract
Background: Genes that are co-expressed tend to be involved in the same biological process. 
However, co-expression is not a very reliable predictor of functional links between genes. The 
evolutionary conservation of co-expression between species can be used to predict protein 
function more reliably than co-expression in a single species. Here we examine whether co­
expression across multiple species is also a better prioritizer of disease genes than is co-expression 
between human genes alone.
Results: W e use co-expression data from yeast (S. cerevisiae), nematode worm (C. elegans), fruit 
fly (D. melanogaster), mouse and human and find that the use of evolutionary conservation can 
indeed improve the predictive value of co-expression. The effect that genes causing the same 
disease have higher co-expression than do other genes from their associated disease loci, is 
significantly enhanced when co-expression data are combined across evolutionarily distant species. 
W e also find that performance can vary significantly depending on the co-expression datasets used, 
and just using more data does not necessarily lead to better prioritization. Instead, we find that 
dataset quality is more important than quantity, and using a consistent microarray platform per 
species leads to better performance than using more inclusive datasets pooled from various 
platforms.
Conclusion: W e find that evolutionarily conserved gene co-expression prioritizes disease 
candidate genes better than human gene co-expression alone, and provide the integrated data as a 
new resource for disease gene prioritization tools.
Background
In the past few years several bioinformatic tools and 
approaches have been developed to assist medical genetic 
researchers in positional candidate disease gene identifi­
cation (reviewed in [1]; see also [2-5]). Several tools use 
functional genomics to prioritize candidate genes located 
within disease-associated genomic loci by evaluating 
functional relationships between known disease genes
and positional candidate genes [6-8]. These tools are 
based on the premise that genes which are involved in the 
same disease phenotype are likely to be functionally 
related [1,9,10]. This has indeed been shown to be the 
case as evidenced by the fact that these tools all perform 
better than random expectation in the prediction or prior­
itization of candidate disease genes. Nevertheless, not all 
types of functional genomic data perform equally well in
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terms of sensitivity and specificity [2,7,8]. Microarray 
expression data have wider coverage than other high- 
throughput genomic data such as protein-protein interac­
tions, as genome-scale expression analyses are readily and 
routinely performed with them. Additionally, they are less 
biased toward better studied genes than gene function 
annotation or literature mining, although the latter 
approaches fare better at prioritizing disease candidate 
genes [2,7,8]. Therefore, given the large coverage of co­
expression data and their complementarity to functional 
annotation and literature mining, it is of importance to 
maximize the disease gene predictive value of this type of 
data.
Several bioinformatic candidate disease gene prioritiza­
tion tools already incorporate microarray-based co­
expression data [2,6-8,11,12]. This approach is based on 
the assumption that if two genes are functionally related 
then their expression should vary concordantly across tis­
sues and under different circumstances, and proposes that 
their expression profiles should therefore be correlated. 
For candidate disease gene prioritization, the use of co­
expression analysis is preferable to the use of tissue-spe­
cific gene expression patterns, as it is a better predictor of 
functional relatedness between genes [13].
However, co-expression data can be applied more com­
prehensively than is currently implemented by these 
tools. One im portant and currently underexploited 
approach is to incorporate co-expression data from other 
species. One might expect that while hum an co-expres­
sion data are the most relevant for disease gene prioritiza­
tion, evolutionary conservation of co-expression can be 
used to enhance the reliability of identified co-expression 
relationships. The premise is that co-expression relation­
ships that are maintained across phylogenetically distant 
organisms m ust be under selective pressure, and should 
therefore be functional -  a premise that has indeed been 
confirmed in several previous studies [14-17]. Though 
one tool already includes multi-species co-expression data
[11], the improvement in disease gene ranking perform­
ance due to the exploitation of evolutionary conservation 
has not yet been investigated.
We therefore investigated the predictive value of con­
served co-expression for candidate disease gene prioritiza­
tion. To this end we analyzed how well co-expression 
between known and candidate disease genes could prior­
itize positional candidate disease genes. We restricted our 
analysis to known disease genes from genetic diseases 
containing at least two known causative genes. We con­
structed artificial loci of 100 candidate genes around the 
known disease-causing genes, and investigated the ten­
dency of these causative genes to have higher co-expres­
sion with other known causative genes compared to the
non-causative candidate genes from the same disease loci. 
Using co-expression data from five eukaryotic species -  
baker's yeast (Saccharomyces cerevisiae), nematode worm 
(Caenorhabditis elegans), fruit fly (Drosophila melanogaster), 
mouse (Mus musculus) and hum an -  we investigated the 
effect of evolutionary conservation on the ranking of the 
disease gene pairs, finding that evolutionary conservation 
of co-expression does indeed improve disease gene rank­
ing. Therefore, exploiting evolutionary conservation 
could potentially improve the performance of co-expres­
sion data in existing disease candidate gene prioritization 
tools [2,6-8], which might in turn improve the prioritiza­
tion of less well-studied genes.
Results
Evolutionary conservation of co-expression improves 
disease gene ranking performance
We investigated how well disease genes tend to rank rela­
tive to non-causative candidate disease genes when 
ranked according to co-expression with other genes 
known to cause the same disease. We combined co­
expression scores across species using orthology relation­
ships from the euKaryotic clusters of Orthologous Groups 
(KOG) database [18]. The co-expression scores are thus 
based on these KOGs rather than on individual genes (see 
methods section for further details). We used expression 
data from human, mouse, fruit fly (D. melanogaster), 
worm (C. elegans) and baker's yeast (S. cerevisiae) assem­
bled from the Gene Expression Omnibus database [19] 
and the Genomics Institute of the Novartis Foundation 
[20] Gene Atlas expression data. For this study we used 
artificial disease loci containing 100 genes per locus. Test­
ing with 50, 100 and 200 genes per locus does not make 
much difference though smaller loci tend to perform 
slightly better than larger loci (data not shown). Only dis­
ease gene pairs with co-expression scores unlikely to occur 
randomly in the corresponding dataset (i.e. more than 2 
standard deviations from the dataset randomization 
mean) were included in the final rankings. This process 
implicitly weighs the scores according to the number of 
species involved, as the random score distributions are 
narrower for datasets combining more species. The stand­
ard deviations of these randomized distributions range 
from 0.051 for the five-species combined dataset to 
between 0.057 (yeast) and 0.094 (mouse) for the individ­
ual single-species datasets. Therefore, a given correlation 
score is more likely to be considered significant in a m ulti­
species dataset than in a single-species dataset.
Genes whose co-expression is conserved through evolu­
tion have been shown to have stronger functional ties 
than genes whose co-expression is no t [17]. Therefore, 
conserved co-expression between species should improve 
disease gene ranking over co-expression in one species 
alone. Such a trend is indeed apparent (Figure 1). Both for
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Evolutionary conservation o f co-expression im proves disease candidate gene p rio ritiza tion  perform ance over 
hum an-only co-expression. The disease gene rank histogram shows the relative proportions of disease genes scoring in dif­
ferent rank bins based on co-expression with known disease genes causing the same disease. Disease gene rank indicates its 
degree of co-expression with known disease genes, relative to those of the other locus candidate genes. Evolutionary conser­
vation results in a much higher proportion of disease genes ranking in the top l0% of the locus candidate genes and fewer in 
the mid-regions of the lists. A) Disease gene rank histogram. B) Cumulative proportion of disease genes detected as the co­
expression rank threshold is decreased from l to 0.
hum an and for multi-species KOG-based co-expression 
sets, disease gene pairs generally score in the upper half of 
the co-expression rankings for the KOG-mappable genes 
in the disease loci and are significantly better than ran­
dom expectation (medians 0.64 and 0.69 for human-only 
and conserved co-expression sets respectively; p << 10-16 
for both sets, Wilcoxon signed rank test). Therefore, the 
causative disease gene in a candidate locus will generally 
rank higher than the other locus candidate genes. Further­
more, the multi-species combined co-expression set per­
forms significantly better than the human-only co­
expression set (medians 0.64 and 0.69 respectively, p < 
10-6, Wilcoxon rank sum test), indicating that the use of 
evolutionary conservation can significantly improve co­
expression-based candidate disease gene ranking.
Given that co-expression-based disease gene ranking is 
only sensible if there is a non-random co-expression rela­
tionship between the disease genes, we further narrowed 
down the analysis to only those disease gene pairs that are 
likely to be genuinely co-expressed, having scores that are 
unlikely to occur randomly in their datasets. This substan­
tially improves the rankings (Figure 2), at the expense of
reduced coverage (695 versus 3286 disease gene rank­
ings). Both the human-only and the conserved co-expres­
sion datasets now rank the disease genes very high 
(medians of 0.87 and 0.93 respectively), with the con­
served co-expression still significantly outperforming the 
human-only co-expresssion (p < 10-11, Wilcoxon rank 
sum test). A much higher proportion of disease genes is 
now ranked in the top 10% of the candidate gene lists, 
and the use of evolutionary conservation increases this 
proportion by almost half, from 31% to 44% of the 
ranked disease genes.
Disease gene ranking improved by co-expression 
conservation at different evolutionary distances
Evolutionary conservation across multiple species clearly 
improves the disease gene ranking performance of gene 
co-expression. However, what influence might different 
evolutionary distances have on this improvement? Is the 
evolutionary distance between hum an and mouse suffi­
cient to improve co-expression performance, and is yeast 
biology so divergent that it would reduce rather than 
improve performance? To examine the role of evolution­
ary distance on the disease gene ranking performance of
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Filtering  out insignificant co-expression im proves perform ance. When disease gene pairs with co-expression scores 
that do not differ significantly from those of randomized datasets are filtered out, the disease gene ranking performance 
improves substantially. However, the coverage drops from 3286 to 695 pairs. A) Disease gene rank histogram. B) Cumulative 
proportion of disease genes detected as the co-expression rank threshold is decreased from 1 to 0.
gene co-expression, we conducted pairwise comparisons 
in which we compared the ranking performance hum an 
co-expression with co-expression conserved between 
hum an and each of the other species. For all pairwise 
comparisons except the human-yeast comparison, evolu­
tionary conservation significantly improves co-expres­
sion-based disease gene ranking compared to using only 
data for hum an genes (Figure 3, Table 1). Surprisingly, 
even human-mouse conservation improves disease gene 
ranking despite the relatively short evolutionary distance 
between these two species.
In contrast to the other species, co-expression conserva­
tion with yeast does not significantly improve disease 
gene ranking (Table 1). For this species pair yeast-only co­
expression performs best, outperforming even the com­
bined human-yeast set at ranking hum an disease genes 
(albeit no t significantly; p = 0.26). This is primarily due to 
specific disease types involving housekeeping processes 
such as metabolism (congenital disorder of glycosylation, 
glycogen storage disease) and DNA repair (xeroderma pig­
mentosum) which consistently score well particularly in 
the yeast set. As yeast co-expression already performs very 
well, the combination with hum an co-expression may not 
yield much extra information. However, this performance 
comes at the expense of much reduced coverage of disease
genes relative to the other sets, which all have a similar 
coverage (550 disease gene rankings for the human-yeast 
set, versus ~3000 for human-mouse, human-fly and 
human-worm sets). It is thus evident that despite the large 
evolutionary distance between these two species, yeast co­
expression is still effective at ranking hum an disease genes 
for those genes that have orthologs in both species.
Disease gene ranking performance is dependent on co­
expression data used
We initially used the multi-species co-expression dataset 
from Stuart and colleagues [21], bu t this resulted in lim­
ited disease gene ranking performance. We suspected that 
the extensive pooling of expression data from different 
platforms might have a negative impact on performance. 
Therefore, we created our own custom multi-species co­
expression dataset, in which we restricted ourselves to a 
single microarray platform per species. Consistent with 
the findings of others [22,23], this single platform 
approach resulted in significantly better performance, 
even when using only the four species included in the Stu­
art et al. dataset (Figure 4). Though both datasets tend to 
rank disease genes highly, the new (GEO/GNF) dataset 
performs significantly better than the larger and more 
inclusive dataset from Stuart and colleagues (p < 10-10, 
Wilcoxon rank sum test) without loss of coverage (3286
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Figure 3
Co-expression-based disease gene rankings are  im proved by conservation a t various evolutionary distances.
Pairwise cross-species co-expression improves disease gene ranking over single-species datasets for comparisons between 
human and mouse (A), fruit fly (B), and nematode worm (C) co-expression. However, co-expression in yeast alone performs 
as well as co-expression conserved between human and yeast (D), and significantly better than human-only co-expression (p =
0.01).
and 3212 disease gene rankings for the GEO/GNF and the In addition to restricting expression data to a single plat- 
Stuart et al. datasets respectively). form per species, normalizing the microarray expression
data according to total expression level also improves the 
ranking of disease genes relative to non-disease genes
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T a b le  1: P a irw ise  species co m p a riso n s  fo r  co -exp re ss ion -based  disease gene ra n k in g .
Individual species #  Disease gene pairs Median rank Pairwise combined sets #  Disease gene pairs Median rank P-value (Combined be tter 
than single species)
Human 3286 0.64 Human-Mouse 3114 0.67 6.7 x |0-4 *
Mouse 3188 0.63 1.3 x |0-5 *
Human 3286 0.64 Human-Fly 3176 0.66 0.007 *
Fly 3534 0.62 1.8 x |0-5 *
Human 3286 0.64 H um an-W orm 2954 0.67 2.1 x |0-4 *
W o rm 3264 0.63 9.1 x |0-6 *
Human 3286 0.64 Human-Yeast 550 0.67 0.12
Yeast 674 0.69 0.74
*  statistically significant at p = 0.05 level
from the candidate loci. As we were mainly interested in All disease gene ranking and conserved co-expression cor­
relative expression levels of genes across conditions and relation data presented here are freely available online 
not in total gene expression levels, we normalized all [24]. 
expression values according to the total expression level of 
the microarray sample (see methods section for further Discussion
details). This reduces systematic biases between samples In this study, we show that we can increase the predictive 
due to differences in total expression levels and highlights value of co-expression for disease gene prioritization by 
the expression relationships between genes per sample, exploiting evolutionary conservation, despite the varia- 
resulting in up to 5% improvement in candidate disease tions in the biology of the species compared. Given a gen­
gene ranking (data no t shown). uine co-expression relationship between the disease
genes, using conserved co-expression to prioritize candi-
KOG-based disease gene rankings (Hs, Dm, Ce, Sc) 
(histograms)
Stuart et al. 
GEO+GNF
KOG-based disease gene rankings (Hs, Dm, Ce, Sc) 
(cumulative distributions)
0.4-0 .5  0.6-0 .7  
Relative Rank Rank Threshold
Figure 4
Single p la tfo rm  co-expression dataset outperform s m ultip le  p latform  co-expression dataset. The more cohesive 
GEO/GNF set containing a single microarray platform per species outperforms the more inclusive multi-platform Stuart et al. 
set (p < I0-10). Both sets have similar coverage, with 3212 and 3286 disease gene pairs for the Stuart et al. and GEO/GNF sets 
respectively. These results are based on co-expression data from human, fly, worm and yeast, with co-expression scores are 
averaged across species wherever possible. A) Disease gene rank histogram. B) Cumulative proportion of disease genes 
detected as the co-expression rank threshold is decreased from I to 0.
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date disease genes can reduce the number of genes to be 
tested over sevenfold compared to using a random rank­
ing of the candidate disease genes, as the correct gene will 
be found on average after testing 7% of the candidates 
(the m edian disease gene rank is 0.93) instead of 50% 
(Figure 2). Encouragingly, even human-mouse conserva­
tion can lead to a substantial improvement in disease gene 
ranking performance, despite the relatively short evolu­
tionary distance between these two species (Figure 3). 
This means that improvements in specificity can be 
gained without large losses in sensitivity, as m ost hum an 
genes have mouse orthologs.
An interesting finding is that large pooled datasets which 
combine as many expression data as possible from vari­
ous experiments and platforms can actually result in 
reduced co-expression performance relative to smaller but 
more coherent expression datasets (Figure 4). Microarray 
data are notoriously variable between independently gen­
erated datasets while they are somewhat more consistent 
between experiments using the same platform [22,23]. In 
order to minimize dilution of the co-expression signal 
when combining data from many different sources a 
weighting scheme is required, such as using the co-expres­
sion overlap between different sets to weigh the relevance 
of the co-expression value [25]. Our results are consistent 
with these previously reported findings, as our single-plat- 
form-per-species dataset ranks disease genes significantly 
better than the more inclusive pooling approach adopted 
earlier by Stuart and colleagues [21]. An alternative expla­
nation would be that their expression sets are of lower 
quality or are less representative of the relationships 
between disease genes, but there is no reason to assume 
that either of these is the case. This underscores the fact 
that combining as many data as possible does not neces­
sarily lead to an improved performance of co-expression 
data for disease gene prioritization, so it is therefore not a 
trivial finding that combining data from different species 
does.
Another reason why the larger sets do not perform as well 
as the smaller sets could lie in the use of correlation coef­
ficients to determine genetic relatedness. Correlation coef­
ficients estimate expression coherence across all 
conditions surveyed, but even functionally related genes 
may not have coherent expression patterns across all tis­
sues and conditions. The larger the datasets, the greater 
the potential for irrelevant conditions to mask the co­
expression relationship that a group of genes has under a 
limited set of conditions. Therefore, a biclustering-based 
approach [26,27] may yield more refined co-expression 
relationships between genes, and is a potential avenue for 
future improvement of co-expression-based disease candi­
date gene prioritization.
Conclusion
We analyze here the predictive power of gene co-expres­
sion for disease gene prioritization and identify factors 
that affect it, such as evolutionary conservation. We show 
that co-expression data from other species have predictive 
power for hum an disease gene prioritization, and that 
evolutionarily conserved gene co-expression can improve 
disease gene prioritization over human-only gene co­
expression. In addition, we show that platform consist­
ency is important and that smaller but more cohesive 
datasets can outperform larger pooled datasets. Though 
we only examined disease gene ranking, these findings 
have broader relevance for the use of microarray co­
expression data in functional genomics. We provide these 
conserved co-expression data as a new resource that can 
be used in disease gene prioritization programs, particu­
larly those that integrate several different data types.
Methods 
Disease data
We used the Online Mendelian Inheritance in Man 
(OMIM) [28] Morbid Map as a source of genetic diseases 
and known disease genes. We restricted our analysis to 
those diseases with two or more known disease genes. 
There were 890 known disease genes (727 distinct genes) 
for 177 diseases in our dataset. Artificial disease loci were 
constructed around these known disease genes based on 
localization information from the Ensembl database [29], 
by taking the required number of neighboring genes cen­
tered on the disease gene. These genes were then trans­
lated to HGNC gene IDs [30] or KOG IDs [18] depending 
on the analysis. This means that the locus genes used in 
the analyses are a subset of the Ensembl genes in the locus, 
depending on how many could be mapped to their rele­
vant IDs. We used artificial loci of 100 genes, which is rep­
resentative for the average candidate disease locus, as the 
OMIM heterogeneous disease loci have a median of 88 
genes per locus. In addition, we investigated the use of 50- 
and 200-gene artificial loci, as well as actual associated 
loci from OMIM Morbid Map, but do not consider them 
further as their results did not differ substantially from 
those of the 100-gene artificial loci.
Expression data processing
Initially we used the multi-species expression data used by 
Stuart and colleagues in their functional analysis of con­
served co-expression [21]. This dataset contains expres­
sion data for human, fruit fly (Drosophila melanogaster), 
nematode worm (Caenorhabditis elegans) and baker's yeast 
(Saccharomyces cerevisiae) genes. These expression data 
had already been normalized and were therefore not fur­
ther processed prior to their use in  the co-expression cal­
culations.
Page 7 of 13
(page number not for citation purposes)
BMC Bioinformatics 2008, 9:208 http://www.biomedcentral.eom/1471-2105/9/208
However, due to limited performance of this dataset in 
ranking disease genes we created a new multi-species co­
expression dataset involving expression data from these 
four species and mouse (Mus musculus). For hum an and 
mouse expression data we used the gcRMA-normalized 
Gene Atlas expression sets generated by the Genomics 
Institute of the Novartis Foundation [20], as this is an 
often-used and well-constructed expression dataset. The 
expression values were log2-transformed to increase 
robustness and emphasize the variation between the 
lower expressed genes relative to the more highly 
expressed ones. Lacking similar standard expression data­
sets for the other species, the expression data for fruit fly 
(Drosophila melanogaster), nematode worm (Caenorhabdi- 
tis elegans) and baker's yeast (Saccharomyces cerevisiae) 
were collected from the Gene Expression Omnibus (GEO) 
database [19] of the National Center for Biotechnology 
Information (NCBI). In order to maximize consistency of 
the expression data, only one expression platform was 
used per species. As these expression data are normalized 
in different ways in different experiments, we used the raw 
signal intensity data (Affymetrix CEL files) rather than the 
normalized expression data. This further restricted the 
data available to us, as these raw data are not required for 
submission of expression data to the GEO database and 
are not included with all datasets. Only experiments with 
at least 10 microarray samples were considered. We ended 
up with 357 samples in 12 experiments for yeast, 242 
samples in 8 experiments for fly and 123 samples in a sin­
gle experiment for worm (Table 2). For within-array nor­
malization we used the Robust Multi-array Averaging
T a b le  2: G E O  exp ress ion  d a tase ts  used
Species GEO series ID
Fly GSE65I5
GSEI690
GSE2780
GSE2828
GSE3069
GSE3842
GSE47I4
GSE4235
W o rm  GSE2I80
Yeast GSE4807
GSE6073 
GSEI3I I, G SEI3I2, GSEI3I3 
GSEI639 
GSEI693 
GSEI934 
GSEI938 
GSEI975 
GSE2343 
GSE3076 
GSE382I 
GSE4I35
(RMA) algorithm [31] as implemented in the R statistical 
software bioconductor library [32]. However, our 
between-array normalization was done by normalizing 
for total sample expression (see below), as we found this 
to yield better results than RMA-normalizing per experi­
m ent (data not shown). Total expression normalization 
prevents spurious correlation due to differences in total 
expression level between samples. For the yeast and fly 
datasets, data were pooled across all experiments before 
total expression normalization and calculation of the co­
expression correlation coefficients.
The Affymetrix probe set expression levels were translated 
to gene expression levels, and for genes that were repre­
sented by multiple probe sets the median was taken. These 
genes were further filtered according to gene sets used 
(Table 3). Both GEO and GNF datasets were further nor­
malized according to total sample expression level by 
dividing each gene expression value by the mean expres­
sion value of all considered genes in the microarray sam­
ple. This further minimizes spurious correlations due to 
differences in total expression level between experimental 
conditions or across tissues.
No artificial cut-off was used to filter out noisy low expres­
sion values, or to define presence or absence of gene 
expression in a sample. This is not necessary, as we are 
using correlation between expression profiles rather than 
absolute expression levels. The inclusion of non-biologi- 
cally significant noise should not result in spurious corre­
lations between genes, and if there is a correlation
N um ber o f samples Reference
78 [36]
I0 [37]
I0 [38]
I2 [39]
I8 [40]
72 [4 I ]
30 [42]
I2 [43]
I23 [44]
30 [45]
I2 [46]
66 [47]
I8 [48]
26 [49]
24 [50]
15 [5 I ]
28 [52]
I2 [53]
96 [54]
I6 [55]
I4 [56]
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T a b le  3: G enes in c lu d e d  in th e  co -e xp re ss io n  ca lcu la tio n s
Species Genes included in co-expression data N um ber o f genes
Human Those w ith  gene names also present in A ffym e trix  H G -U I3 3 A  m icroarray platform I3955 (I I4 I0  genes in all disease loci combined)
Mouse Those w ith  mouse gene names (unknown transcripts, RIKEN transcripts and predicted 
genes excluded)
I4000
Fly Those w ith  FlyBase IDs 13282
W o rm W orm Base-annotated genes I7948
Yeast Those w ith  systematic names (Y...IDs) 6563
between low expression values then they are probably not 
merely noise and should not be filtered out.
It should be noted that while we used log2-transformed 
signal intensity values in a multi-species study involving 
different microarray platforms, and not relative abun­
dances as Liao & Zhang did [16], our analysis does not suf­
fer from the same problems that led them to use relative 
abundances. We do not directly compare expression val­
ues between different microarray platforms. Instead, these 
expression values are converted to co-expression values 
for each platform separately. This process involves only 
within-platform signal intensity comparisons. The 
between-species -  and therefore between-platform -  com­
parisons are done at the co-expression level and involve 
comparisons of Spearman rank correlation coefficients.
Co-expression score calculations
We used Spearman rank correlation coefficients as the 
microarray signal intensity values were not normally dis­
tributed. For the GEO datasets comprising several experi­
ments (the fly and yeast sets), these data were pooled 
before gene pair co-expression correlation coefficients 
were calculated.
In order to be able to compare co-expression relationships 
between species, we used the gene orthology relationships 
as defined by the euKaryotic clusters of Orthologous 
Groups (KOG) database [18]. We chose to use KOGs 
instead of a metagenes-based approach such as was used 
by Stuart and colleagues [21] in order to maximize cover­
age, as KOGs not only contain bidirectional best hits but 
also closely related paralogs. The gene to KOG mapping 
was done using the STRING database version 6.1 [33]. 
Mapping of the protein IDs used in STRING to the gene 
IDs used on the microarrays was done using Ensembl 
BioMart [34]. O f the 13955 hum an genes with expression 
data used in this study 8186 could be mapped to KOGs.
A single pair of KOGs can have multiple co-expression val­
ues if one or both of them contain multiple genes per spe­
cies. In such a case these co-expression scores need to be 
combined into a single co-expression score representative 
of all pairwise combinations of genes in the two KOGs 
(Figure 5). We accomplished this by taking the mean of all
such gene pair co-expression scores, resulting in a single 
KOG-based co-expression score (within-species averag­
ing) .
In order to incorporate evolutionary conservation into the 
final co-expression scores, we took the m ean of the spe­
cies-specific KOG-based co-expression scores over all spe­
cies considered (between-species averaging). For the 
comparison between hum an and multi-species conserved 
co-expression the union of all the sets was taken for max­
imal coverage -  i.e. all KOG-based co-expression scores 
were used regardless of which species were represented in 
the KOGs.
Disease gene ranking analyses
We investigated the co-expression ranking performance 
between candidate disease genes and known disease genes 
for each pair of disease genes causing the same disease 
(Figure 6). To this end we ordered all co-expression values 
between a known disease gene and the genes in a candi­
date disease locus, and scored the relative rank (0-1) of 
the actual causative gene in the resultant list. If the causa­
tive gene was at the top of the list it was assigned a relative 
rank of 1.0, and if at the bottom  it received a relative rank 
of 0.0. A score of 0.5 indicates an equal num ber of more 
highly co-expressed and less highly co-expressed non-dis­
ease genes in the candidate locus, and is equivalent to ran­
dom expectation. For each disease each causative gene was 
sequentially treated as the known disease gene and tested 
against all the other loci.
To avoid ranking candidate disease genes which do not 
have any co-expression relationship with each other at all, 
we randomly permuted the co-expression datasets used to 
determine the random distribution of co-expression 
scores for each dataset. We then excluded all disease gene 
pairs for which the co-expression score fell within 2 stand­
ard deviations of the randomization means. These distri­
butions all had co-expression scores with a mean of 
approximately zero and standard deviations ranging 
between 0.05 and 0.09 depending on the dataset. Multi­
ple randomizations always resulted in almost identical 
score distributions per dataset due to the large numbers 
involved.
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F ig u re5
Procedure fo r calculating conserved co-expression scores. The procedure is illustrated using an example involving 
KOGs KOGOOII and KOG3438 between human and fly. KOGOOII contains two genes in each species (RAD23A, RAD23B 
and FBgn0026777, FBgn0039I47 in human and fly respectively) while KOG3438 contains one in human (CKSIB) and two in fly 
(FBgn00I03I4 and FBgn0037613). For each species a K O G 00II-K O G 3438 co-expression (thick purple and green arrows) 
correlation is calculated by taking the mean of all gene-gene combinations (thin black arrows) for the two KOGs. The mean of 
these species-specific KOG-pair correlations (thick vertical orange arrow) is taken to represent the final multispecies 
K O G 00II-K O G 3438 co-expression correlation. This co-expression value is used for all relevant gene-pairs as their KOG- 
based co-expression score. If co-expression is conserved in both species then this value will be high, if it is high in only one spe­
cies it will be intermediate, and if it is low in both it will be low.
To investigate the influence of evolutionary conservation 
on disease gene pair ranking performance, human- 
derived co-expression data were compared with co-expres­
sion data averaged across all five species included in the 
study. Additionally, pairwise species comparisons were 
performed comparing human-only co-expression data 
with pairwise conserved co-expression between hum an 
and mouse, fly, worm or yeast.
In order to test for the effect of averaging gene-gene co­
expression within KOGs, the performance of the GNF
hum an expression set when using KOG-based co-expres­
sion was compared to its performance when using gene- 
based co-expression.
Tools
The R statistical software package [35] was used for the 
microarray data processing and the Spearman rank corre­
lation calculations, as well as for statistical tests and data 
plotting. For performance reasons, small custom-written 
C++ programs were used to average the gene-gene correla­
tion coefficients into KOG-KOG correlation coefficients,
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Gene Pair SCC
A E 0.9
A C 0.6
A F 0.2
A B 0.1
A D - 0.3
*
Gene Pair Rank
A E 1.0
A C 0.75
A F 0.5
A B 0.25
A D 0.0
Figure 6
Disease gene ranking procedure. Co-expression Spearman correlation coefficients (SCC) are determined for all candidate 
disease genes from a disease locus with known causative gene (E) and another gene known to cause the same disease (A). The 
SCCs are ranked, and the ranks are subsequently normalized to the 0.0—1.0 range. The relative position of the causative gene 
in the locus (E) is determined. This procedure would subsequently be repeated with E as known disease gene and A as candi­
date disease gene. For each disease, each gene is treated as a candidate disease gene in turn and its co-expression is succes­
sively compared to all other genes known to cause the same disease, leading to a list of scores per disease.
and the per-species KOG-KOG correlations into cross-spe­
cies KOG-KOG correlation values. Python scripts were 
written for the disease gene correlation coefficient ranking 
analyses. All scripts and source code are available on 
request.
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